Noel Natoli, MD
Plastic and Reconstructive Surgery · Garden City, NYNPI 1174740401
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (43.6%), consulting fees and grants — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by AbbVie at 26.9% of the total. Reporting peaked in 2024 at $4,919 and has fallen 71.8% since, to $1,386 in 2025.
Across 85 payments — averaging $133.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Smith+Nephew$3K
- Sientra, Inc.$2K
- Kerecis Limited$2K
- Axogen$732
- Davol Inc.$628
- plus $994 from 11 others
What the payments were for
- Consulting fees$2,42021%
- Speaking & faculty fees$540%
- Grants$2,09518%
- Travel & lodging$1,0749%
- Food & beverage$4,95244%
- Education$7697%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 11 | $3,061 |
| Smith+Nephew | 8 | $2,581 |
| Sientra, Inc. | 27 | $1,846 |
| Kerecis Limited | 6 | $1,522 |
| Axogen | 8 | $732 |
| Davol Inc. | 6 | $628 |
| Musculoskeletal Transplant Foundation Inc. | 5 | $371 |
| Mentor Worldwide LLC | 4 | $195 |
| Bard Peripheral Vascular, Inc. | 2 | $143 |
| Galderma Laboratories, L.p. | 1 | $52 |
| Merz North America, Inc. | 1 | $48 |
| Integra Lifesciences Corporation | 1 | $45 |
| Aroa Biosurgery Incorporated | 1 | $45 |
| Baxter Healthcare | 1 | $35 |
| Sanara Medtech Inc. | 1 | $26 |
| Tepha Inc | 1 | $18 |
| Acelrx Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Marigen$4,854
- PICO$2,420
- Kerecis Omega3 SurgiClose$1,213
- SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$1,126
- Kerecis SurgiClose$908
- REVOLVE$714
- NATRELLE SALINE-FILLED BREAST IMPLANTS$714
- ALLODERM$667
- Phasix Mesh$597
- AVANCE NERVE GRAFT$412
- AxoGuard Nerve Connector$412
- AxoGuard Nerve Protector$412
- AXOGUARD HA+ NERVE PROTECTOR$412
- AxoGuard Nerve Cap$412
- Kerecis GraftGuide$227
- MENTOR MemoryGel Resterilizable Gel Sizer$116
How this compares
$11,364 in reported general payments places this provider in the 85th percentile of 219 plastic and reconstructive surgery providers in New York.
See all plastic and reconstructive surgery providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 13 | $26 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Garden City
- Thomas DavenportGarden City$2.8M
- Matthew KilgoGarden City$14K
- Jerry ChangGarden City$14K
- Haritha VeeramachaneniGarden City$7K
- Finny GeorgeGarden City$6K
- Barry DouglasGarden City$5K
- Alexander DagumGarden City$5K
- Howard LangsteinRochester$350K
- James BradleyNew Hyde Park$306K
- David FuntWoodmere$295K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.